INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo INTRASITE* GEL

SCHEDULING STATUS:
Not scheduled.

PROPRIETARY NAME
(and dosage form):

INTRASITE* GEL

COMPOSITION:
Each sachet of 15 g gel contains 0,267 g
crilanomer.
Each sachet of 25 g gel contains 0,445 g crilanomer.

PHARMACOLOGICAL CLASSIFICATION:
A 14 2 Wound dressings

PHARMACOLOGICAL ACTION:
INTRASITE GEL is a Graft-T starch copolymer hydrogel which is chemically stable and inert. It acts by absorbing exudate, bacteria and toxins from the wound surface, thereby preventing slough formation. The effective rehydrating action can produce rapid debridement of necrotic wounds and removal of slough without damaging fragile granulation tissue.

INDICATIONS:
INTRASITE GEL is a dressing for cavity wounds, extravasation injuries, venous ulcers and decubitous ulcers (pressure sores).

CONTRA-INDICATIONS:
INTRASITE GEL should not be used on infected wounds.
INTRASITE GEL is for external use only and should not be taken by mouth.

WARNINGS:
The initial application of INTRASITE GEL should be under the direction of a health professional. For external use only.

DOSAGE AND DIRECTIONS FOR USE:
1. Prepare the wound site by irrigating with a sterile solution e.g. saline.
2. Swab sachet with antiseptic solution. For small wounds, tear vertically across at the first notch to give a narrow aperture. For more extensive wounds, tear vertically across at the second notch to give a wide aperture.
3. Introduce into the wound by squeezing the sachet and allowing INTRASITE GEL to pack the wound. Discard any surplus get.
4. Smooth INTRASITE GEL over the surface of the wound to a minimum depth of 5 mm.
5. Cover wound with a secondary dressing.
The frequency with which the dressing should be changed is highly dependant on the amount of exudate produced by the wound. INTRASITE GEL should not be left in place in the wound longer than 3 days.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
No adverse side effects have been reported.

IDENTIFICATION:
Sterile, colourless to slightly yellow, transparent, aqueous gel, free from contaminants.

PRESENTATION:
Ten sachets containing 15 g or 25 g of the gel in a carton.

STORAGE INSTRUCTIONS:
Store below 25°C in a dry place.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
Y/14.2/324

NAME AND BUSINESS ADDRESS OF APPLICANT:
S & N Pharmaceuticals (Pty) Limited
30 Gillitts Road
Pinetown 3610

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
10 January 1992

* Trademark
PINETOWN
PRINTERS

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998